This course is a fast-paced peek into the therapeutic pipeline. Drugs ranging from new glaucoma medications, to dry eye, uveitis, retinal disease in phase II or III trials will be discussed. New infectious agents and even treatments for Ischemic Optic neuropathy and rare diseases will be covered.
August 23, 2017
By clicking the box, I certify that I am the person who logged in to AOA's EyeLearn and will personally view this course.